FDA Inspection 1266407 — Department of Defense - Army

Department of Defense - Army — FEI 2977443

The FDA completed an inspection of Department of Defense - Army on March 21, 2025 in Tripler Army Medical Center, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 21, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tripler Army Medical Center, HI (United States)